日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors

基于共识的分类工作流程,用于从实体瘤患者的全面基因组分析中确定遗传推断的祖源

Wallen, Zachary D; Nesline, Mary K; Pabla, Sarabjot; Gao, Shuang; Vanroey, Erik; Hastings, Stephanie B; Ko, Heidi; Strickland, Kyle C; Previs, Rebecca A; Zhang, Shengle; Conroy, Jeffrey M; Jensen, Taylor J; George, Elizabeth; Eisenberg, Marcia; Caveney, Brian; Sathyan, Pratheesh; Ramkissoon, Shakti; Severson, Eric A

Development of a workflow for identification of nuclear genotyping markers for Cyclospora cayetanensis

开发用于鉴定环孢子虫核基因分型标记的工作流程

Houghton, Katelyn A; Lomsadze, Alexandre; Park, Subin; Nascimento, Fernanda S; Barratt, Joel; Arrowood, Michael J; VanRoey, Erik; Talundzic, Eldin; Borodovsky, Mark; Qvarnstrom, Yvonne

Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors

用于评估有条件复制能力(溶瘤)鼠腺病毒载体的新型免疫活性鼠肿瘤模型

Michael Robinson, Betty Li, Ying Ge, Derek Ko, Satya Yendluri, Thomas Harding, Melinda VanRoey, Katherine R Spindler, Karin Jooss

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

局部分泌抗CTLA-4可增强癌症免疫疗法的疗效,并减少全身自身免疫的证据。

Simmons, Andrew D; Moskalenko, Marina; Creson, Jennifer; Fang, Jianmin; Yi, Saili; VanRoey, Melinda J; Allison, James P; Jooss, Karin

GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action

GM-CSF分泌型癌症免疫疗法:作用机制的临床前分析

Simmons, Andrew D; Li, Betty; Gonzalez-Edick, Melissa; Lin, Carol; Moskalenko, Marina; Du, Thomas; Creson, Jennifer; VanRoey, Melinda J; Jooss, Karin

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

多西他赛给药不会抑制分泌GM-CSF的肿瘤细胞疫苗的抗肿瘤疗效。

Prell, Rodney A; Gearin, Lisa; Simmons, Andrew; Vanroey, Melinda; Jooss, Karin